These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials. Hernández-Blanco B; Catala-López F Vet Microbiol; 2015 Oct; 180(1-2):1-9. PubMed ID: 26249827 [TBL] [Abstract][Full Text] [Related]
24. Molecular characterisation and nucleotide sequence analysis of canine parvovirus strains in vaccines in India. Nandi S; Anbazhagan R; Kumar M Vet Ital; 2010; 46(1):69-81. PubMed ID: 20391369 [TBL] [Abstract][Full Text] [Related]
25. Are vaccine strain, type or administration protocol risk factors for canine parvovirus vaccine failure? Altman KD; Kelman M; Ward MP Vet Microbiol; 2017 Oct; 210():8-16. PubMed ID: 29103701 [TBL] [Abstract][Full Text] [Related]
26. New variants of canine parvovirus in dogs in southern Brazil. de Oliveira PSB; Cargnelutti JF; Masuda EK; Weiblen R; Flores EF Arch Virol; 2019 May; 164(5):1361-1369. PubMed ID: 30859474 [TBL] [Abstract][Full Text] [Related]
27. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus. Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445 [TBL] [Abstract][Full Text] [Related]
28. Determination of immune status in dogs against CPV-2 by recombinant protein based latex agglutination test. Thomas J; Singh M; Goswami TK; Glora P; Chakravarti S; Chander V; Upmanyu V; Verma S; Sharma C; Mahendran K Biologicals; 2017 Sep; 49():51-56. PubMed ID: 28689674 [TBL] [Abstract][Full Text] [Related]
29. Recombinant vaccine for canine parvovirus in dogs. López de Turiso JA; Cortés E; Martínez C; Ruiz de Ybáñez R; Simarro I; Vela C; Casal I J Virol; 1992 May; 66(5):2748-53. PubMed ID: 1313899 [TBL] [Abstract][Full Text] [Related]
30. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin. Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693 [TBL] [Abstract][Full Text] [Related]
31. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen]. Truyen U Tierarztl Prax; 1994 Dec; 22(6):579-84. PubMed ID: 7716757 [TBL] [Abstract][Full Text] [Related]
32. Canine Parvovirus is diagnosed and neutralized by chicken IgY-scFv generated against the virus capsid protein. Ge S; Xu L; Li B; Zhong F; Liu X; Zhang X Vet Res; 2020 Sep; 51(1):110. PubMed ID: 32883344 [TBL] [Abstract][Full Text] [Related]
33. No evidence for a role of modified live virus vaccines in the emergence of canine parvovirus. Truyen U; Geissler K; Parrish CR; Hermanns W; Siegl G J Gen Virol; 1998 May; 79 ( Pt 5)():1153-8. PubMed ID: 9603330 [TBL] [Abstract][Full Text] [Related]
34. Substitutions at residues 300 and 389 of the VP2 capsid protein serve as the minimal determinant of attenuation for canine parvovirus vaccine strain 9985-46. Sehata G; Sato H; Yamanaka M; Takahashi T; Kainuma R; Igarashi T; Oshima S; Noro T; Oishi E J Gen Virol; 2017 Nov; 98(11):2759-2770. PubMed ID: 28984228 [TBL] [Abstract][Full Text] [Related]
35. Maternally-derived antibodies in pups and protection from canine parvovirus infection. Decaro N; Campolo M; Desario C; Elia G; Martella V; Lorusso E; Buonavoglia C Biologicals; 2005 Dec; 33(4):261-7. PubMed ID: 16168665 [TBL] [Abstract][Full Text] [Related]
36. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c. Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778 [TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of partial VP-2 gene amplified from rectal swab samples of diarrheic dogs in Pakistan confirms the circulation of canine parvovirus genetic variant CPV-2a and detects sequences of feline panleukopenia virus (FPV). Ahmed N; Riaz A; Zubair Z; Saqib M; Ijaz S; Nawaz-Ul-Rehman MS; Al-Qahtani A; Mubin M Virol J; 2018 Mar; 15(1):45. PubMed ID: 29544546 [TBL] [Abstract][Full Text] [Related]
38. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose. Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389 [TBL] [Abstract][Full Text] [Related]
39. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection. Larson LJ; Schultz RD Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379 [TBL] [Abstract][Full Text] [Related]
40. Monitoring of canine parvovirus (CPV) strains detected in vaccinated puppies in Brazil. Castro TX; Costa EM; Leite JP; Labarthe NV; Cubel Garcia RC Res Vet Sci; 2011 Apr; 90(2):336-40. PubMed ID: 20609453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]